Massive Overreaction!, page-3

I am always very supportive Australia biotech pharma and sirtex is one of those.
They need to do more than talk. If sir still to be used at salvage stage, there is no chance competing with oral tablet .They need to move up to the cascade.
I am average down abit to $18.5 now. But wouldn't be buying more until next update.
To be honest I am really pessimistic now after hearing the investor call just now.
The only thing we will see above $25 is with new positive clinical data
Dyor